• Title/Summary/Keyword: discovery DNA

Search Result 157, Processing Time 0.024 seconds

CEO's Innovation DNA and Innovation : Fit of Environment (경영자 혁신DNA와 혁신 : 환경 적합성)

  • Kim, Seung Ho;Huh, Moo Yul
    • Asia-Pacific Journal of Business Venturing and Entrepreneurship
    • /
    • v.10 no.1
    • /
    • pp.95-110
    • /
    • 2015
  • Most innovation related theories including entrepreneurship theory regard the CEO's innovative competencies as the starting point of innovation. The study was investigated the relationship between CEO's innovation DNA and Innovation and the effects of environmental fit in their relation. For the empirical test, the sample was collected from 110 manufacturing companies in Daegu and Gyeongbook region. The results as follows: First, Innovation DNA has generally significant positive effect on innovation. The effect of discovery DNA is stronger than operating DNA to the product innovation, but the operating DNA stronger than the discovery DNA to the process innovation. The fit between CEO's innovative DNA and exogenous environmental turbulence make a strength innovation. The supplementary fit between discovery DNA and technology turbulence and complementary fit between discovery DNA and market turbulence reinforce product innovation. Process innovation were strengthen by the complementary fit between operating DNA and market turbulence.

  • PDF

Discovery of the DNA double helix structure as a model of Liberal Education for Engineers (공학소양교육 사례로서의 DNA 구조 발견)

  • Nam, Young
    • Journal of Engineering Education Research
    • /
    • v.21 no.6
    • /
    • pp.54-62
    • /
    • 2018
  • This study is an analysis of the process of the discovery of the DNA double helix structure from an engineering literacy education perspective. The explanation of the DNA double helix structure by James Watson and Francis Crick in 1952 is a well-known scientific episode. The process is also a combination of various incidents that can frequently happen in competitive engineering research and development situations. Therefore, the process of the discovery of the DNA structure is a remarkable event that can cover all subjects, such as engineering and ethics, research ethics, communication between researchers, engineering and leadership, engineering and teamwork, and engineering and women. This paper focuses on analyzing the research ethics issues associated with Rosalind Franklin and comparing and analyzing the three teams that were very close to the discovery of the DNA structure. By looking at why the Watson and Crick team got the final answer instead of the Linus Pauling's team or the Maurice Wilkins and Rosalind Franklin's team, the virtues of the technology development process that should be taught in engineering literacy education will be naturally presented.

The Effects of Innovator's DNA on the Innovative Strategy in SMEs (중소기업 경영자의 혁신DNA와 혁신전략에 관한 연구)

  • Kim, Seung Ho;Bae, Seung Hyun;Jun, In;Park, Jong Ho;Son, Kang Ho
    • Asia-Pacific Journal of Business Venturing and Entrepreneurship
    • /
    • v.9 no.6
    • /
    • pp.199-212
    • /
    • 2014
  • Recently, there are increasing to the interest in the organizational innovation DNA as the innovation origin and these interest mainly were approached through the case analysis of global innovative companies. The purpose of study is to investigate the applicability under the CEO of SMEs settings as global companies' cases. The research focused on the impact of innovator's DNA on innovative strategy by the empirical study that analyzed from 110 firm's data in Daegu and Gyeongbuk region. The results of empirical study, innovator's DNA has positive effects on the overall innovative strategy, especially the effects of discovery DNA are stronger than operational DNA. Included to the discovery DNA effects, operational DNA bring about negative on the product differentiation, though it has positive on the market differentiation. In terms of components of innovator's DNA, the questioning and association have strong impacts on the overall innovative strategy, and analyzing has positive on market differentiation, but specific task implementation has negative on the product differentiation. The results suggest that the logic of global innovation case is possible to the SME's CEO and need to learning efforts to promote discovery DNA for successful innovation.

  • PDF

DNA chip technology

  • Lee, Sang-Yeop;Yun, Seong-Ho;Choe, Jong-Gil;Im, Geun-Bae
    • 한국생물공학회:학술대회논문집
    • /
    • 2000.11a
    • /
    • pp.119-122
    • /
    • 2000
  • Biological science is being revolutionized by the availability of much sequence information from many genome project With the advanced technology at hand, main trend in biological research is rapidly changing from a structural DNA analysis to understanding cellular function of the DNA sequences. Combined with mechanics, computer, bioinformatics and other advanced technologies, DNA chip technology provides numerous applications because of its robustness, accuracy, and automation. DNA chip is expected to become an indispensable tool in fields of biology, biotechnology, drug discovery, and other application areas. DNA chip can be used for mutation and polymorphism detection, gene expression monitoring and phenotypic analysis as well. If DNA chip is used for the development of pharmaceutical products, it can considerably reduce the cost and time for the entire process of drug discovery and development, and can also contribute in developing personal drugs.

  • PDF

Interleukin-18 Binding Protein (IL-18BP): A Long Journey From Discovery to Clinical Application

  • Soohyun Kim;Hyeon Yu;Tania Azam;Charles A. Dinarello
    • IMMUNE NETWORK
    • /
    • v.24 no.1
    • /
    • pp.1.1-1.6
    • /
    • 2024
  • IL-18 binding protein (IL-18BP) was originally discovered in 1999 while attempting to identify an IL-18 receptor ligand binding chain (also known as IL-18Rα) by subjecting concentrated human urine to an IL-18 ligand affinity column. The IL-18 ligand chromatography purified molecule was analyzed by protein microsequencing. The result revealed a novel 40 amino acid polypeptide. To isolate the complete open reading frame (ORF), various human and mouse cDNA libraries were screened using cDNA probe derived from the novel IL-18 affinity column bound molecule. The identified entire ORF gene was thought to be an IL-18Rα gene. However, IL-18BP has been proven to be a unique soluble antagonist that shares homology with a variety of viral proteins that are distinct from the IL-18Rα and IL-18Rβ chains. The IL-18BP cDNA was used to generate recombinant IL-18BP (rIL-18BP), which was indispensable for characterizing the role of IL-18BP in vitro and in vivo. Mammalian cell lines were used to produce rIL-18BP due to its glycosylation-dependent activity of IL-18BP (approximately 20 kDa). Various forms of rIL-18BP, intact, C-terminal his-tag, and Fc fusion proteins were produced for in vitro and in vivo experiments. Data showed potent neutralization of IL-18 activity, which seems promising for clinical application in immune diseases involving IL-18. However, it was a long journey from discovery to clinical use although there have been various clinical trials since IL-18BP was discovered in 1999. This review primarily covers the discovery of IL-18BP along with how basic research influences the clinical development of IL-18BP.

Elevated level of PLRG1 is critical for the proliferation and maintenance of genome stability of tumor cells

  • Hyunji Choi;Moonkyung Kang;Kee-Ho Lee;Yeon-Soo Kim
    • BMB Reports
    • /
    • v.56 no.11
    • /
    • pp.612-617
    • /
    • 2023
  • Pleiotropic regulator 1 (PLRG1), a highly conserved element in the spliceosome, can form a NineTeen Complex (NTC) with Prp19, SPF27, and CDC5L. This complex plays crucial roles in both pre-mRNA splicing and DNA repair processes. Here, we provide evidence that PLRG1 has a multifaceted impact on cancer cell proliferation. Comparing its expression levels in cancer and normal cells, we observed that PLRG1 was upregulated in various tumor tissues and cell lines. Knockdown of PLRG1 resulted in tumor-specific cell death. Depletion of PLRG1 had notable effects, including mitotic arrest, microtubule instability, endoplasmic reticulum (ER) stress, and accumulation of autophagy, ultimately culminating in apoptosis. Our results also demonstrated that PLRG1 downregulation contributed to DNA damage in cancer cells, which we confirmed through experimental validation as DNA repair impairment. Interestingly, when PLRG1 was decreased in normal cells, it induced G1 arrest as a self-protective mechanism, distinguishing it from effects observed in cancer cells. These results highlight multifaceted impacts of PLRG1 in cancer and underscore its potential as a novel anti-cancer strategy by selectively targeting cancer cells.

Drosophila melanogaster: a Model for the Study of DNA Damage Checkpoint Response

  • Song, Young-Han
    • Molecules and Cells
    • /
    • v.19 no.2
    • /
    • pp.167-179
    • /
    • 2005
  • The cells of metazoans respond to DNA damage by either arresting their cell cycle in order to repair the DNA, or by undergoing apoptosis. This response is highly conserved across species, and many of the genes involved in this DNA damage response have been shown to be inactivated in human cancers. This suggests the importance of DNA damage response with regard to the prevention of cancer. The DNA damage checkpoint responses vary greatly depending on the developmental context, cell type, gene expression profile, and the degree and nature of the DNA lesions. More valuable information can be obtained from studies utilizing whole organisms in which the molecular basis of development has been well established, such as Drosophila. Since the discovery of the Drosophila p53 orthologue, various aspects of DNA damage responses have been studied in Drosophila. In this review, I will summarize the current knowledge on the DNA damage checkpoint response in Drosophila. With the ease of genetic, cellular, and cytological approaches, Drosophila will become an increasingly valuable model organism for the study of mechanisms inherent to cancer formation associated with defects in the DNA damage pathway.

SEREX; discovery of tumor antigens (종양 항원의 발견: SEREX)

  • Lee, Sang-Yull
    • Journal of Life Science
    • /
    • v.17 no.6 s.86
    • /
    • pp.841-846
    • /
    • 2007
  • The identification of tumor antigens is essential for the development of anticancer therapeutic vaccines and clinical diagnosis of cancer. SEREX (serological analysis of recombinant cDNA expression library)has been used to identify such tumor antigens by screening sera of cancer patients with cDNA ex-pression libraries. SEREX-defined antigens provide markers for the diagnosis of cancers. SEREX is also a powerful method for the development of anticancer therapeutics. The development of anticancer vaccines requires that tumor antigens can elicit antigen-specific antibodies or T lymphocytes. This re-view provides information on the application of SEREX for discovery of tumor antigens.

Enhancement of DNA Vaccine-induced Immune Responses by Influenza Virus NP Gene

  • Choi, So-Young;Suh, You-Suk;Cho, Jae-Ho;Jin, Hyun-Tak;Chang, Jun;Sung, Young-Chul
    • IMMUNE NETWORK
    • /
    • v.9 no.5
    • /
    • pp.169-178
    • /
    • 2009
  • DNA immunization induces B and T cell responses to various pathogens and tumors. However, these responses are known to be relatively weak and often transient. Thus, novel strategies are necessary for enhancing immune responses induced by DNA immunization. Here, we demonstrated that co-immunization of influenza virus nucleoprotein (NP) gene significantly enhances humoral and cell-mediated responses to codelivered antigens in mice. We also found that NP DNA coimmunization augments in vivo proliferation of adoptively transferred antigen-specific CD4 and CD8 T cells, which enhanced protective immunity against tumor challenge. Our results suggest that NP DNA can serve as a novel genetic adjuvant in cocktail DNA vaccination.